Vantaggi
Rigel used to be an excellent place to work in Research & Development. Salaries were above industry standards. Great benefits package. Innovative research, novel disease indications pursued, and terrific resources allocated in research (equipment & budgets). Small company where you know most of the employees. Very generous with stock options grants given out annually.
Svantaggi
Rigel has been plagued with many clinical failures. Half of research was laid off in September 2016 (just below the number of employees and the % of company that would trigger the WARN act) and I suspect the days are numbered for all the other employees remaining in research. Not a transparent company. The two biology groups were not collaborative to the point of being secretive. Several high level employees 'retired' according to emails/press releases in the last two years, but that is clearly not true for two or three of these individuals. The new HR department takes pride in getting new hires at the lowest salary possible (below industry standards), has reduced the frequency of promotions and salary increases, and in general has had a negative effect on the workplace.